Search by Drug Name or NDC

    NDC 00023-6150-04 Crinone 45 mg/1.125g Details

    Crinone 45 mg/1.125g

    Crinone is a VAGINAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is PROGESTERONE.

    Product Information

    NDC 00023-6150
    Product ID 0023-6150_da3178d8-d328-4d13-8e3f-18acc75e54d4
    Associated GPIs 55370060004010
    GCN Sequence Number 034383
    GCN Sequence Number Description progesterone, micronized GEL/PF APP 4 % VAGINAL
    HIC3 G2A
    HIC3 Description PROGESTATIONAL AGENTS
    GCN 96805
    HICL Sequence Number 020653
    HICL Sequence Number Description PROGESTERONE, MICRONIZED
    Brand/Generic Brand
    Proprietary Name Crinone
    Proprietary Name Suffix n/a
    Non-Proprietary Name progesterone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GEL
    Route VAGINAL
    Active Ingredient Strength 45
    Active Ingredient Units mg/1.125g
    Substance Name PROGESTERONE
    Labeler Name Allergan, Inc.
    Pharmaceutical Class Progesterone [CS], Progesterone [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020701
    Listing Certified Through 2024-12-31

    Package

    NDC 00023-6150-04 (00023615004)

    NDC Package Code 0023-6150-04
    Billing NDC 00023615004
    Package 6 APPLICATOR in 1 CARTON (0023-6150-04) / 1.125 g in 1 APPLICATOR
    Marketing Start Date 1997-05-13
    NDC Exclude Flag N
    Pricing Information N/A